Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.26
(0.23%)
USD 26.26
(0.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 90.55 Million USD | 43.25% |
| 2022 | 63.21 Million USD | 16.49% |
| 2021 | 54.26 Million USD | 57.7% |
| 2020 | 34.4 Million USD | -0.02% |
| 2019 | 34.41 Million USD | 38.49% |
| 2018 | 24.85 Million USD | 87.29% |
| 2017 | 13.26 Million USD | 31.23% |
| 2016 | 10.11 Million USD | 124.19% |
| 2015 | 4.51 Million USD | 695.41% |
| 2014 | 567 Thousand USD | 5570.0% |
| 2013 | 10 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 24.03 Million USD | -4.07% |
| 2024 Q2 | 36.4 Million USD | 51.45% |
| 2023 Q2 | 23.47 Million USD | 31.62% |
| 2023 Q3 | 24.19 Million USD | 3.1% |
| 2023 FY | 90.55 Million USD | 43.25% |
| 2023 Q4 | 25.05 Million USD | 3.53% |
| 2023 Q1 | 17.83 Million USD | 25.9% |
| 2022 Q3 | 16.1 Million USD | -4.09% |
| 2022 Q1 | 16.15 Million USD | 6.94% |
| 2022 Q4 | 14.16 Million USD | -12.04% |
| 2022 FY | 63.21 Million USD | 16.49% |
| 2022 Q2 | 16.78 Million USD | 3.91% |
| 2021 Q4 | 15.1 Million USD | 9.76% |
| 2021 Q2 | 13.71 Million USD | 17.51% |
| 2021 FY | 54.26 Million USD | 57.7% |
| 2021 Q1 | 11.67 Million USD | 9.52% |
| 2021 Q3 | 13.76 Million USD | 0.34% |
| 2020 Q2 | 4.85 Million USD | -40.72% |
| 2020 Q4 | 10.65 Million USD | -0.42% |
| 2020 FY | 34.4 Million USD | -0.02% |
| 2020 Q1 | 8.19 Million USD | -9.38% |
| 2020 Q3 | 10.7 Million USD | 120.41% |
| 2019 Q3 | 8.69 Million USD | 4.86% |
| 2019 Q4 | 9.03 Million USD | 3.97% |
| 2019 Q1 | 8.39 Million USD | 15.24% |
| 2019 Q2 | 8.29 Million USD | -1.2% |
| 2019 FY | 34.41 Million USD | 38.49% |
| 2018 Q1 | 4.79 Million USD | 23.56% |
| 2018 Q4 | 7.28 Million USD | 11.21% |
| 2018 FY | 24.85 Million USD | 87.29% |
| 2018 Q2 | 6.22 Million USD | 29.89% |
| 2018 Q3 | 6.54 Million USD | 5.15% |
| 2017 Q3 | 3.08 Million USD | -13.7% |
| 2017 Q2 | 3.56 Million USD | 30.26% |
| 2017 Q1 | 2.74 Million USD | 0.66% |
| 2017 FY | 13.26 Million USD | 31.23% |
| 2017 Q4 | 3.88 Million USD | 25.97% |
| 2016 Q2 | 2.73 Million USD | 28.28% |
| 2016 FY | 10.11 Million USD | 124.19% |
| 2016 Q1 | 2.13 Million USD | 37.02% |
| 2016 Q4 | 2.72 Million USD | 7.93% |
| 2016 Q3 | 2.52 Million USD | -7.79% |
| 2015 Q2 | 917 Thousand USD | 64.93% |
| 2015 Q1 | 556 Thousand USD | 223.26% |
| 2015 Q4 | 1.55 Million USD | 5.06% |
| 2015 FY | 4.51 Million USD | 695.41% |
| 2015 Q3 | 1.48 Million USD | 61.5% |
| 2014 Q4 | 172 Thousand USD | -14.85% |
| 2014 Q1 | 2000.00 USD | -20.0% |
| 2014 FY | 567 Thousand USD | 5570.0% |
| 2014 Q2 | 191 Thousand USD | 9450.0% |
| 2014 Q3 | 202 Thousand USD | 5.76% |
| 2013 Q3 | 2500.00 USD | 0.0% |
| 2013 Q1 | 2500.00 USD | 0.0% |
| 2013 Q2 | 2500.00 USD | 0.0% |
| 2013 Q4 | 2500.00 USD | 0.0% |
| 2013 FY | 10 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -105.67 Thousand USD | 85790.088% |
| BIMI International Medical Inc. | 1.94 Million USD | -4543.863% |
| China Jo-Jo Drugstores, Inc. | 31.1 Million USD | -191.087% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 90.55 Million USD | 0.0% |
| Leafly Holdings, Inc. | 37.45 Million USD | -141.791% |
| Leafly Holdings, Inc. | 37.45 Million USD | -141.791% |
| LifeMD, Inc. | 126.01 Million USD | 28.141% |
| LifeMD, Inc. | 126.01 Million USD | 28.141% |
| TRxADE HEALTH, Inc. | 2.59 Million USD | -3385.144% |
| PetMed Express, Inc. | 78.64 Million USD | -15.137% |
| Walgreens Boots Alliance, Inc. | 26.52 Billion USD | 99.659% |